Albert Einstein Healthcare Network
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Albert ranks #44,562 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.
- #44,562
- of 49,997 US assignees by volume
- 4th percentile
- by Innovation Score (17.7/100)
- 10.8
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R44562 · US Corporation #44,562 · 5 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 5 grants
- LOWER-Q #44,562/49,997
- PHOTO-FINISH Akos Biosciences
- CPC-NARROW A61B · 2 areas
- INNOV-LOW 17.7/100
- CLAIMS-PAR 10.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Akos Biosciences, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Albert’s 17.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Albert
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Albert Einstein… · this assignee 18
Albert Einstein… · this assignee
18 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Albert's Innovation Score is 17.7/100 (4th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Albert?
Each dot is one of Albert’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Albert’s own 10.8 claims/patent is at or below the 11.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Albert's grants concentrate
Albert Einstein Healthcare Network is a focused PatentsView assignee: 2 CPC subclasses with 60% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, Albert sits between Akos Biosciences, Inc. and Alef Edge Inc.
Who files at Albert's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Akos Biosciences
Akos Biosciences, Inc.
5 patents
- Akrion Systems
Akrion Systems, LLC
5 patents
- Akwel Sweden AB
Akwel Sweden AB
5 patents
- Albea Lacrost
Albea Lacrost
5 patents
- Alcon Components
Alcon Components Limited
5 patents
- Alder Biopharmace…
Alder Biopharmaceuticals, Inc.
5 patents
- Aleees ECO ARK
Aleees ECO ARK Co. Ltd.
5 patents
- Alef Edge
Alef Edge Inc
5 patents
- Albert Einstein H… ◀
Albert Einstein Healthcare Network
5 patents
What this shows Albert holds 5 patents at rank #44,477, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Albert
By rank, the assignees closest to #44,477 in granted patent volume.
- Akos Biosciences, Inc. #44,473 · 5 patents
- Akrion Systems, LLC #44,474 · 5 patents
- Akwel Sweden AB #44,475 · 5 patents
- Albea Lacrost #44,476 · 5 patents
- Alcon Components Limited #44,478 · 5 patents
- Alder Biopharmaceuticals, Inc. #44,479 · 5 patents
- Aleees ECO ARK Co. Ltd. #44,480 · 5 patents
- Alef Edge Inc #44,481 · 5 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Albert's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Albert's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
18 4th percentile higher than 4% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 20.0% |
| 2016 | 2 | 40.0% |
| 2018 | 1 | 20.0% |
| 2019 | 1 | 20.0% |
Which technologies does Albert Einstein Healthcare Network patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Albert Einstein Healthcare Network's patent record in context - here's where to go next.
- Albert Einstein Healthcare Network's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 60% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #44,562 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Albert Einstein Healthcare Network against Akos Biosciences, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 17.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.